These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18713448)

  • 21. Acute generalized exanthematous pustulosis associated with oral terbinafine.
    Hall AP; Tate B
    Australas J Dermatol; 2000 Feb; 41(1):42-5. PubMed ID: 10715900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model selection in estimating equations.
    Pan W
    Biometrics; 2001 Jun; 57(2):529-34. PubMed ID: 11414579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overdispersion in modelling accidents on road sections and in empirical bayes estimation.
    Hauer E
    Accid Anal Prev; 2001 Nov; 33(6):799-808. PubMed ID: 11579982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of hierarchical Bayesian models for overdispersed count data using DIC and Bayes' factors.
    Millar RB
    Biometrics; 2009 Sep; 65(3):962-9. PubMed ID: 19173704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral antifungal agents for onychomycosis.
    Wilson NJ; White SI
    Lancet; 1998 May; 351(9114):1516. PubMed ID: 9605836
    [No Abstract]   [Full Text] [Related]  

  • 29. Is terbinafine responsible for eliciting positive patch tests performed with Lamisil tablets?
    Barbaud A; Reichert-Penetrat S; Granel F; Kolopp-Sarda MN; Schmutz JL
    Contact Dermatitis; 1999 Aug; 41(2):101. PubMed ID: 10445692
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Griseofulvin and/or Terbinafine Induced Toxic Epidermal Necrolysis in an Adult Female Patient - A Case Report.
    Jadeja D; Jaiswal CS; Panchasra A; Tripathi CB
    Curr Drug Saf; 2016; 11(2):192-4. PubMed ID: 26695069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximum likelihood estimation of the negative binomial dispersion parameter for highly overdispersed data, with applications to infectious diseases.
    Lloyd-Smith JO
    PLoS One; 2007 Feb; 2(2):e180. PubMed ID: 17299582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study.
    Vena GA; Micali G; Santoianni P; Cassano N; Peruzzi E
    Int J Immunopathol Pharmacol; 2005; 18(4):745-53. PubMed ID: 16388724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction intervals for overdispersed binomial data with application to historical controls.
    Menssen M; Schaarschmidt F
    Stat Med; 2019 Jun; 38(14):2652-2663. PubMed ID: 30835886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Painfree and accurate Bayesian estimation of psychometric functions for (potentially) overdispersed data.
    Schütt HH; Harmeling S; Macke JH; Wichmann FA
    Vision Res; 2016 May; 122():105-123. PubMed ID: 27013261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up.
    Svejgaard EL; Brandrup F; Kragballe K; Larsen PO; Veien NK; Holst M; Andersen BL; Bro-Jørgensen AV; Dahl JC; Frentz G; Graudal C; Kamp P; Kroman N; Larsen FS; Mikkelsen F; Munkvad JM; Olafsson JH; Rothenborg H; Staberg B; Søndergaard J; Thulin H
    Acta Derm Venereol; 1997 Jan; 77(1):66-9. PubMed ID: 9059684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral terbinafine (Lamisil) in the short-term treatment of fungal infections of the skin: results of a post-marketing surveillance study.
    Binder M; Nell G
    Mycoses; 1999; 42(9-10):555-8. PubMed ID: 10592700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terbinafine and taste loss.
    Veraldi S; Pontini P; Serini SL
    G Ital Dermatol Venereol; 2016 Jun; 151(3):308-9. PubMed ID: 27176083
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypersensitivity syndrome reaction to oral terbinafine.
    Gupta AK; Porges AJ
    Australas J Dermatol; 1998 Aug; 39(3):171-2. PubMed ID: 9737044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.